DDW 2022

A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.

Presenting at DDW 2022, researchers identified the risk factors associated with the development of early-onset advanced colorectal neoplasia in young adults.

Normalization of 2 factors can foretell the potential for recurrence in patients who were in remission, according to a report.

Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.

Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia (AN) and colorectal cancer (CRC).

Researchers evaluated liver test abnormalities in patients hospitalized with COVID-19 and assessed cytokine levels in individuals with vs without abnormal test results.

While food allergies may affect response to the medication, environmental allergies do not, the report says.

A team of researchers investigated the association between postoperative recurrence of Crohn disease and a patient’s sex and race and ethnicity.

Researchers sought to determine the prevalence of cardiovascular disease, cirrhosis, metabolic diseases, and chronic kidney disease in lean vs overweight or obese NAFLD.

Researchers evaluated the effects of antibiotic exposure, specifically cumulative use, timing of use, and the association with older-onset IBD.